Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox’s Positive Post Hoc Results from NCX 4251 Phase 2b Mississippi Trial Suggest Path Forward in Dry Eye Disease

November 30, 2021

View Press Release Corporate presentation Contact us
Previous